New Products October 2021

ichorbio has released five new biosimilars targeting PD-1 and PD-L1. The biosimilars are as follows:

Sintilimab Biosimilar – Research Grade [ICH5001]

Toripalimab Biosimilar – Research Grade [ICH5002]

Camrelizumab – Research Grade [ICH5003]

Tislelizumab Biosimilar – Research Grade [ICH5004]

Durvalumab Biosimilar – Research Grade [ICH5052]

 

Leave a Reply

Your email address will not be published. Required fields are marked *